Successful treatment of Aspergillus prosthetic valve endocarditis with oral voriconazole

Clin Infect Dis. 2005 Sep 1;41(5):752-3. doi: 10.1086/432580. Epub 2005 Jul 20.

Abstract

Aspergillus endocarditis is very difficult to cure, even with aggressive surgical debridement and antifungal therapy. Patients with embolic involvement of the central nervous system have an extremely poor prognosis. We describe a patient with prosthetic valve endocarditis due to Aspergillus fumigatus who developed emboli in the brain, eye, and lower extremities. With aggressive surgical debridement of involved sites, aortic valve and root replacement, and long-term therapy with oral voriconazole, he remains without any evidence of infection 2 years later.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents / therapeutic use
  • Aspergillosis / drug therapy*
  • Endocarditis / drug therapy*
  • Endocarditis / microbiology*
  • Heart Valve Prosthesis / microbiology*
  • Humans
  • Male
  • Pyrimidines / therapeutic use*
  • Triazoles / therapeutic use*
  • Voriconazole

Substances

  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • Voriconazole